EUVIMEDEUVIMED entdecken
Open Access

Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP)

Sudipta Bar, Tyler A U Hilsabeck, Blaine Pattavina, José Alberto López-Domínguez, Nathan Basisty, Joanna Bons, Mark Watson, Birgit Schilling, Judith Campisi, Pankaj Kapahi, Amit Sharma

Aging · 2025

DOI: 10.18632/aging.206224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2025. Verfasst von Sudipta Bar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Buck Institute for Research on Aging, Novato, CA 94945, USA. Hauptthemen laut MEDLINE: Cellular Senescence, ADAM Proteins, Senescence-Associated Secretory Phenotype, Drosophila Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceADAM ProteinsSenescence-Associated Secretory PhenotypeDrosophila ProteinsAnimalsHumansMicePermeabilityDNA DamageGenome-Wide Association StudyAging

Stichwörter der Autor:innen

SASPagingdrosophilasenescence

Substanzen

ADAM ProteinsDrosophila ProteinsADAM19 protein, human

Autor:innen und Institutionen

  • Buck Institute for Research on Aging, Novato, CA 94945, USA.
  • Jackson Laboratory, Farmington, CT 06032, USA.
  • Instituto de Biología Molecular y Celular del Cáncer and Centro de Investigación del Cáncer of Salamanca, University of Salamanca-CSIC, Campus Unamuno s/n, 37007 Salamanca, Spain.
  • National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • SENS Research Foundation, Mountain View, CA 94041, USA.

Förderung

  • NIA NIH HHS
  • NIH HHS

Zitieren

APA

Bar, S., Hilsabeck, T. A. U., Pattavina, B., López-Domínguez, J. A., Basisty, N., Bons, J., Watson, M., Schilling, B., Campisi, J., Kapahi, P., & Sharma, A. (2025). Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP). Aging. https://doi.org/10.18632/aging.206224

Vancouver

Bar S, Hilsabeck TAU, Pattavina B, López-Domínguez JA, Basisty N, Bons J, et al. Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP). Aging. 2025. doi:10.18632/aging.206224

BibTeX
@article{Bar2025,
  author = {Bar, Sudipta and Hilsabeck, Tyler A U and Pattavina, Blaine and López-Domínguez, José Alberto and Basisty, Nathan and Bons, Joanna and Watson, Mark and Schilling, Birgit and Campisi, Judith and Kapahi, Pankaj and Sharma, Amit},
  title = {Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP)},
  journal = {Aging},
  year = {2025},
  doi = {10.18632/aging.206224}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche